fironel 50 mikrogram/dosis næsespray, suspension
mg pharma - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
kalmente 50 mikrogram/dosis næsespray, suspension
alvogen ipco s.a.r.l. - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
mipasu 50 mikrogram/dosis næsespray, suspension
mg pharma - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
sonalox 50 mikrogram/dosis næsespray, suspension
mg pharma - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
netonox 50 mikrogram/dosis næsespray, suspension
substipharm développement - mometasonfuroat - næsespray, suspension - 50 mikrogram/dosis
metmin 50 mikrogram/dosis næsespray, suspension
adamed sp. z.o.o. - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
rinometasone 50 mikrogram/dosis næsespray, suspension
bruschettini - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
rinoter 50 mikrogram/dosis næsespray, suspension
farma group srl - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - medicin for obstruktiv sygdomme, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - medicin for obstruktiv sygdomme, - maintenance treatment of asthma in adults whose disease is not adequately controlled.